KIC Ventures Investor Conference - FY2024 Milestones and FY2025 Outlook

​Dear Investors,

​Happy New Year! As we enter 2025, we thank you for your continued trust and support since KIC’s founding in 2005. Reflecting on the progress we’ve made since launching KIC Ventures in 2013, we’re proud to share our growth, fiscal discipline, and vision for the year ahead. 

​With the U.S. leading the world in spine technology innovation and favorable conditions under new leadership, we’re excited to invite you to our Investor Conference Webinar on Saturday, January 11, 2025, at 10 AM PST / 1 PM EST.

​During this live session, we’ll cover:

​• Q4 2024 Performance – Growth and market adoption highlights

​• FY2024 Milestones & 2025 Pipeline – Key achievements and goals

​• 2025 Strategic Focus – Innovation and market positioning plans

​• AxioMed Outlook – Updates on FDA approval and manufacturing.

​We anticipate significant revenue growth, FDA approval of the AxioMed lumbar disc in the U.S., progress on the cervical disc internationally, and new outpatient spine surgery innovations. These milestones and initiatives position KIC Ventures for sustained success in 2025 and beyond.

​Join us to gain valuable insights into our future. A concise summary transcript will be provided after the event.

Post Event Survey: https://forms.office.com/r/0aXpFDVbWa